The European Tissue and Hygiene Paper Market was valued at globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
Global Dementia Drugs Market Expected to Exceed $19.6 Billion In 2026
- FinancialNewsMedia.com News Commentary
PALM BEACH, Fla., April 20, 2021 /PRNewswire/ While this past year living in quarantine during the pandemic did not just create economical damage, and social disruption… it could have also increased new cases of secondary medical results from the pandemic. According to various reports the outbreak of the COVID-19 pandemic is expected to have a significant impact on the Dementia drugs market. According to a research study by Katya Numbers et al., published in Nature Reviews Neurology, in January 2021, the population with dementia are at high risk of contracting COVID-19 infection as the cognitive symptoms cause difficulty to abide by the safety guidelines that were proposed to contain the viral spread. Furthermore, older populations with dementia are also more likely to have more severe disease consequences than those without dementia. Additionally, the statement from
Dementia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) The global dementia drugs market was valued at approximately USD 12,736. 06 million in 2020 and is expected to witness a revenue of USD 19,655. 10 million in 2026, with a CAGR of 7. 87% over the forecast period.
April 15, 2021 08:24 ET | Source: ReportLinker ReportLinker Lyon, FRANCE
New York, April 15, 2021 (GLOBE NEWSWIRE) Reportlinker.com announces the release of the report Dementia Drugs Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026) - https://www.reportlinker.com/p06062856/?utm source=GNW
The outbreak of the COVID-19 pandemic is expected to have a significant impact on the Dementia drugs market. According to a research study by Katya Numbers et al., published in Nature Reviews Neurology, in January 2021, the population with dementia are at high risk of contracting COVID-19 infection as the cogniti
Cloudera Collaborates with NVIDIA to Accelerate Data Analytics and AI in the Cloud technuter.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from technuter.com Daily Mail and Mail on Sunday newspapers.
Cloudera Collaborates with NVIDIA to Accelerate Data Analytics and AI in the Cloud
Accelerating Cloudera Data Platform with NVIDIA computing makes AI-fueled business transformation a reality
News provided by
Share this article
Share this article
SANTA CLARA, Calif., April 12, 2021 /PRNewswire/ Cloudera, (NYSE: CLDR), the enterprise data cloud company, today announced that
RAPIDS Accelerator for Apache Spark 3.0. Deployed on NVIDIA computing platforms, the software enables enterprises to accelerate data pipelines and push the performance boundaries of data and machine learning (ML) workflows to drive faster AI adoption and deliver better business outcomes, without changing any code. With the release earlier this year of Applied ML Prototypes (AMPs) in CDP and the power of NVIDIA computing, customers like the Internal Revenue Service and the Office for National Statistics UK can not only jumpstart fully packaged ML use cases, but also accelerate data processing and model